Genentech and Eli Lilly produce the first human insulin via genetic engineering: the human insulin gene, sequenced building on Sanger's work, is inserted into E. coli to produce the protein industrially. First recombinant-DNA therapeutic drug approved by the FDA (Humulin, 1982), inaugurating pharmaceutical biotechnology.